Antirheumatic agents. III. Novel methotrexate derivatives bearing an indoline ring and a modified ornithine or glutamie acid

Chemical and Pharmaceutical Bulletin

Volumn 45, Issue 7, 1997, Pages 1146-1150

  Matsuoka, Hiroharu ^a   Kato, Nobuaki ^a   Ohi, Nobuhiro ^a   Miyamoto, Katsuhito ^a   Mihara, Masahiko ^a   Takeda, Yasuhisa ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Anti proliferation; Indoline; Methotrexate; MX 9

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE DERIVATIVE; N DELTA (3 CARBOXYPHENYL) N ALPHA [1 [(2,4 DIAMINOPTERIDIN 6 YL)METHYL]INDOLIN 5 YLCARBONYL]GLUTAMINE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CHEMICAL MODIFICATION; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NORMAL HUMAN;

EID: 0030845452     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.45.1146     Document Type: Article

References (6)

1. a) Matsuoka H., Kato N., Tsuji K., Maruyama N., Suzuki H., Mihara M., Takeda Y., Yano K., Chem. Pharm. Bull., 44, 1332-1337 (1996);
2. b) Matsuoka H., Maruyama N., Suzuki H., Kuroki T., Tsuji K., Kato N., Ohi N., Mihara M., Takeda Y., Yano K., ibid., 44, 2287-2293 (1996).
3. Furst D. E., Kremer J. M., Arth. Rheum., 31, 305-314 (1988).
4. Piper J. R., McCaleb G. S., Montgomery J. A., J. Med. Chem., 26, 291-294 (1983).
5. Piper J. R., Montgomery J. A., J. Org. Chem., 42, 208-211 (1977).
6. Oefner C., D'Arcy A., Winkler F. K., Eur. J. Biochem., 174, 377-385 (1988).